Nanotechnology in drug and gene delivery

32Citations
Citations of this article
124Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Over the last decade, nanotechnology has widely addressed many nanomaterials in the biomedical area with an opportunity to achieve better-targeted delivery, effective treatment, and an improved safety profile. Nanocarriers have the potential property to protect the active molecule during drug delivery. Depending on the employing nanosystem, the delivery of drugs and genes has enhanced the bioavailability of the molecule at the disease site and exercised an excellent control of the molecule release. Herein, the chapter discusses various advanced nanomaterials designed to develop better nanocarrier systems used to face different diseases such as cancer, heart failure, and malaria. Furthermore, we demonstrate the great attention to the promising role of nanocarriers in ease diagnostic and biodistribution for successful clinical cancer therapy.

Cite

CITATION STYLE

APA

Hamimed, S., Jabberi, M., & Chatti, A. (2022, July 1). Nanotechnology in drug and gene delivery. Naunyn-Schmiedeberg’s Archives of Pharmacology. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00210-022-02245-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free